Table 1.
SARS-CoV-2 co-infections identified in Equatorial Guinea.
| Patient | Date of swab collection | Spike gene mutation specific RT-qPCR assay results | Potential lineages involved in co-infection* | |||
|---|---|---|---|---|---|---|
| HV69/70Δ | L452R | E484K | N501Y | |||
| EG-SARS-COV-2-P1 | 12/11/2020 | HV69/70 | NA | E484 + 484K | N501 + 501Y | Wildtype (e.g., B.1.192) + Beta VOC (B.1.351) |
| EG-SARS-COV-2-P2 | 14/11/2020 | HV69/70 | NA | E484 + 484K | N501 + 501Y | Wildtype (e.g., B.1.192) + Beta VOC (B.1.351) |
| EG-SARS-COV-2-P3 | 25/11/2020 | HV69 + 69/70Δ | NA | E484 + 484K | N501 | Wildtype (e.g., B.1.192) + B.1.620 |
| EG-SARS-COV-2-P4 | 25/11/2020 | HV69/70 | NA | E484 + 484K | N501 + 501Y | Wildtype (e.g., B.1.192) + Beta VOC (B.1.351) |
| EG-SARS-COV-2-P5 | 10/08/2021 | HV69/70 | L452 + 452R | E484 + 484K | N501 + 501Y | Beta VOC (B.1.351) + Delta VOC (AY.43) |
| EG-SARS-COV-2-P6 | 30/08/2021 | HV69/70 | L452 + 452R | E484 + 484K | N501 + 501Y | Beta VOC (B.1.351) + Delta VOC (AY.43) |
*Potential lineages involved in co-infections were proposed based on spike gene mutations and known circulating variants at the time.